Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01568879 · ClinicalTrials.gov registry record · NA
Evaluating the Effectiveness of a Chronic Disease Management Program for Gout
A NA study of Recurrent or Tophaceous Gout, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
- 1
- Study location
NCT01568879 is a NA study of Recurrent or Tophaceous Gout that has completed, run by Kaiser Permanente. The registered enrollment target is 104 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01568879, a NA study of Recurrent or Tophaceous Gout, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to test the effectiveness of a pharmacist-staffed, protocol-based chronic disease management program compared to patients receiving usual care in achieving a target serum uric acid level in patients with recurrent gout.
Conditions Studied
Interventions
- OTHER Control
- OTHER Gout Disease Management Program
Study Locations (1)
California
- Kaiser Permanente Northern California Medical Facilities - All KPNC Facilities
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2012-01 |
| Est. Completion | 2014-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01568879
The ClinicalTrials.gov registry entry for NCT01568879 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Recurrent or Tophaceous Gout appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT01568879 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01568879 about?
NCT01568879 is a clinical study titled "Evaluating the Effectiveness of a Chronic Disease Management Program for Gout". The aim of this study is to test the effectiveness of a pharmacist-staffed, protocol-based chronic disease management program compared to patients receiving usual care in achieving a target serum uric acid level in patients with recurrent gout.
What is the current status of trial NCT01568879?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2012-01. Estimated completion is 2014-11.
What conditions does trial NCT01568879 study?
This clinical trial studies the following conditions: Recurrent or Tophaceous Gout.
What interventions are being tested in trial NCT01568879?
The interventions under investigation include: Control (OTHER), Gout Disease Management Program (OTHER).
Who is sponsoring clinical trial NCT01568879?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01568879 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.